Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAROTRECTINIB for Sarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 25 adverse event reports in the FDA FAERS database where LAROTRECTINIB was used for Sarcoma.

Most Reported Side Effects for LAROTRECTINIB

Side Effect Reports % Deaths Hosp.
Fatigue 56 7.0% 5 7
Drug ineffective 52 6.5% 11 3
Dizziness 50 6.3% 1 7
Death 48 6.0% 48 2
Pain 42 5.3% 4 9
Neuropathy peripheral 39 4.9% 2 1
Nausea 32 4.0% 1 5
Off label use 31 3.9% 7 4
Disease progression 27 3.4% 3 1
Malignant neoplasm progression 23 2.9% 6 1
Myalgia 23 2.9% 0 1
Vomiting 23 2.9% 6 14
Drug resistance 19 2.4% 3 1
Anaemia 18 2.3% 3 7
Diarrhoea 18 2.3% 3 9

Other Indications for LAROTRECTINIB

Thyroid cancer (43) Neoplasm (31) Neoplasm malignant (28) Ntrk gene fusion cancer (26) Ntrk gene fusion positive (25) Lung neoplasm malignant (24) Glioblastoma (21) Congenital fibrosarcoma (18) Pancreatic carcinoma (18) Soft tissue sarcoma (18)

Other Drugs Used for Sarcoma

DOXORUBICIN (409) PAZOPANIB (296) IFOSFAMIDE (280) EPIRUBICIN (132) NIVOLUMAB (124) VINCRISTINE (105) CYCLOPHOSPHAMIDE (79) ETOPOSIDE (75) TRABECTEDIN (75) TRONOXAL INYECTABLE (74)

Related Pages

LAROTRECTINIB Full Profile All Sarcoma Drugs LAROTRECTINIB Demographics LAROTRECTINIB Timeline